Wilhelmus Groenhuysen
2017
In 2017, Wilhelmus Groenhuysen earned a total compensation of $3.1M as Chief Financial Officer at NovoCure, a 50% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $360,360 |
---|---|
Option Awards | $1,195,857 |
Salary | $600,600 |
Stock Awards | $929,500 |
Other | $30,765 |
Total | $3,117,082 |
Groenhuysen received $1.2M in option awards, accounting for 38% of the total pay in 2017.
Groenhuysen also received $360.4K in non-equity incentive plan, $600.6K in salary, $929.5K in stock awards and $30.8K in other compensation.
Rankings
In 2017, Wilhelmus Groenhuysen's compensation ranked 3,470th out of 14,666 executives tracked by ExecPay. In other words, Groenhuysen earned more than 76.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 3,470 | 76th |
Manufacturing | 1,197 | 79th |
Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 156 | 82nd |
Surgical, Medical, And Dental Instruments And Supplies | 84 | 84th |
Surgical and Medical Instruments and Apparatus | 53 | 84th |
Groenhuysen's colleagues
We found four more compensation records of executives who worked with Wilhelmus Groenhuysen at NovoCure in 2017.